HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted after early testing
Disease control TerminatedThis early-stage study tested the safety and highest tolerable dose of an experimental drug called INCB062079 in people with advanced liver cancer and other solid tumors. The trial enrolled 25 participants whose cancers had progressed after standard treatments and was designed to…
Matched conditions: HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial aims to stop liver Cancer's return after surgery
Disease control TerminatedThis study tested whether a drug called cadonilimab could help prevent liver cancer from coming back after successful surgery. It focused on patients at high risk of their cancer returning. The trial was terminated early and enrolled 45 participants to assess safety and effective…
Matched conditions: HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC